Perjeta
Drug timelines are a Plus or Pro feature.
74 regulatory and trial events tracked for Perjeta, covering 2012-06-08 to 2026-04-28. Get the full timeline:
Most recent: EMA Authorised: Perjeta (pertuzumab) — Roche Registration GmbH
74 regulatory and trial events tracked for Perjeta, covering 2012-06-08 to 2026-04-28. Get the full timeline:
Most recent: EMA Authorised: Perjeta (pertuzumab) — Roche Registration GmbH